US FDA Approves GSK Asthma Drug – ObserverLeader.com (blog)


Ledger Gazette

US FDA Approves GSK Asthma Drug
ObserverLeader.com (blog)
The U.S. Food and Drug Administration has given the green light to the use of mepolizumab (produced under the name Nucala by GlaxoSmithKline) as treatment in severe cases of asthma for patients of 12 years or older with an eosinophilic phenotype.
FDA approves Mepolizumab for maintenance treatment of severe asthmaLedger Gazette
Nucala approved to treat severe asthmaExaminer.com
Nucala: FDA Approves GSK Drug for Severe AsthmaSMN Weekly (blog)

all 4 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.